PCR was conducted on the saliva sample collected at the time of submission. A saliva swab was immersed in 500 µ1 TE (Tris-ethylenediaminetetraacetic acid) buffer, and total RNA was extracted with RNA TM zol B. b Samples were amplified in 100-µ1 volumes in a Coy Model 60 Tempcycler using a GeneAmp ® RNA-PCR kit c according to manufacturer's instructions with approximately 100 ng total RNA. Oligonucleotide 5' and 3' primers were, respectively, TCACCGCAAGGGAAGCAATA and ACGGGCTTGAT-GATTGGAA, derived from rabies virus nucleic acid sequence (GenBank accession no. X13357). The deduced size of the amplification fragment using these primers should be this animal. 1,2 This dog was exhibiting generalized demodi-550 bp. PCR identified the presence of the rabies virus cosis at the time of rabies vaccination and may not have nucleoprotein in the saliva sample collected at the time of been able to mount an effective immune response to the submission (Fig. 1) .
rabies vaccine. The FAT on fresh brain tissue was positive for rabies antigen. Histologic lesions on formalin fixed tissue were typical of a viral encephalitis and consistent with rabies. The lesions consisted of areas, particularly in the cerebellar white matter and hypothalamus, of variable, mostly lymphocytic, perivascular infiltrates and glial nodules (Fig. 2) . Negri bodies were not observed.
This case demonstrates the importance of keeping domestic animals current on their rabies vaccination schedule. It also illustrates the fact that an immunosuppressed animal may not respond to a vaccine as well as a healthy one and that ordinarily highly antigenic vaccines may not reliably protect immunosuppressed animals.
Monoclonal antibody analysis of the brain tissue revealed the reactivity pattern of the sample to be identical to the rabies nucleoprotein found in skunks in the south-central USA.
